- Home
- SFST vs AMRN Comparison
SFST vs AMRN Comparison
Compare SFST & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SFST | AMRN |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.4M | 339.8M |
| IPO Year | 1999 | 1993 |
Fundamental Metrics
Financial Performance| Metric | SFST | AMRN |
|---|---|---|
| Price | $53.40 | $13.88 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $51.00 | $12.00 |
| AVG Volume (30 Days) | 61.2K | ★ 80.1K |
| Earning Date | 01-27-2026 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.78 | N/A |
| EPS | ★ 3.23 | N/A |
| Revenue | $109,391,000.00 | ★ $226,733,000.00 |
| Revenue This Year | $13.23 | N/A |
| Revenue Next Year | $17.49 | N/A |
| P/E Ratio | $16.92 | ★ N/A |
| Revenue Growth | ★ 21.32 | N/A |
| 52 Week Low | $29.14 | $7.08 |
| 52 Week High | $56.73 | $20.90 |
Technical Indicators
Market Signals| Indicator | SFST | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 64.04 | 32.16 |
| Support Level | $54.64 | $13.64 |
| Resistance Level | $56.10 | $14.49 |
| Average True Range (ATR) | 1.29 | 0.76 |
| MACD | -0.11 | -0.11 |
| Stochastic Oscillator | 49.91 | 11.73 |
Price Performance
Historical ComparisonAbout SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.